AgriMetis® Expands Through Addition of Field Biology Expertise
LUTHERVILLE, MD – March 11, 2019 – AgriMetis, LLC, is pleased to announce Dr. Thomas Hayden has joined the company as Field Biology Lead. Dr. Hayden is welcomed by a growing team of industry veterans who are working to discover, develop, and deliver innovative crop protection compounds to the industry. View the AgriMetis team here: http://www.agrimetis.com/team.
Dr. Hayden will lead all field biology activities within AgriMetis, including the design, management and interpretation of crop protection efficacy and crop safety trials in a field environment. Tom draws on over twenty-five years of experience in field research and new product development in the agricultural products and seed industries. He has worked across the crop protection delivery channel, including time at American Cyanamid, BASF, BASF Plant Science, Cheminova, and Winfield United.
Brian Green, Vice President of Research and Development at AgriMetis, said, “We are excited to have Tom join our team. AgriMetis has been conducting field trials for several years, but as our programs advance toward commercialization and our project pipeline swells, we are ready to expand our capabilities. Tom has a long history of delivering quality field biology results, and we look forward to what we know will be valuable contributions.”
Dr. Hayden remarked, “The AgriMetis approach to delivering innovation is exciting. I am looking forward to helping AgriMetis demonstrate the value of its products in the field and bringing its products to market.”
About AgriMetis: AgriMetis is committed to working with leading agriculture companies and businesses to fill the emerging need for sustainable crop protection products through leading edge and advanced discovery, development and delivery methods. The AgriMetis technology platform is at the interface of biology, biochemistry, and chemistry, employing a multidisciplinary and integrated scientific approach, and allowing access to areas of chemical space and production routes that are inaccessible to others. AgriMetis was formed in March 2014 and completed a Series B financing in December 2016 to fund agriculture chemical research and development by applying a biopharmaceutical model. With headquarters near Baltimore, Maryland, AgriMetis continues to grow and develop its technologies and capabilities. For more information, please visit http://www.agrimetis.com
This press release contains “forward-looking statements” concerning the development and commercialization of AgriMetis products, the potential benefits and attributes of such products, and company expectations regarding prospects. Forward-looking statements are subject to risks, assumptions and uncertainties that could cause actual future events or results to differ materially from such statements. These statements are made as of the date of this press release. Actual results may vary. AgriMetis undertakes no obligation to update any forward-looking statements for any reason.